"Allodynia is a phenomena in which normally non-painful stimulus are perceived as painful. PENS is a peripheral electrical stimulation device which is minimally invasive and non destructive. When tested on capsacin-induced pain and hyperalgesia it had an analgesic effect. It has been used in acute and chronic pain, and has been found to be effective in the management of different pain conditions such as cancer pain associated with bony metastases. It is less invasive than radiofrequency denervation or dorsal column stimulation. Before purchasing a new device our pain department wanted to look at potential benefit to patients with allodynia neuropathic pain."

Click here to see poster...

'Stimulator PENS therapy: innovative technology of interest.

Algotec Research and Development Limited provide innovative electro-analgesic solutions to improve the quality of care for patients suffering from chronic neuropathic pain...'

Click to see article in the Times newspaper.

Through Algotec Research and Development Limited, the Dudley Group of Hospitals NHS Foundation Trusts Pain Service introduced Percutaneous Electrical Nerve Stimulation (PENS) as an additional management Option in 2007, and it has since developed as a predominately Nurse led service.

Percutaneous Electrical Nerve Stimulation (PENS) is a relatively new electro analgesic therapy.

Read more...